PRESS STATEMENTS06.29.2020 Pfizer Statement on Facebook Advertising Boycott06.23.2020 NEW DATA ON THE BURDEN OF EMERGING S. PNEUMONIAE SEROTYPES PUBLISHED IN ISPPD 2020 ONLINE DIGITAL LIBRARY06.16.2020 Merck and Pfizer’s SGLT2 Inhibitor STEGLATROTM (ertugliflozin) Meets Primary Endpoint in VERTIS CV Trial for Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease05.28.2020 Corning and Pfizer Announce Supply Agreement for Corning Valor® Glass Packaging05.01.2020 Pfizer Receives Positive CHMP Opinion for DAURISMO® (glasdegib) for Certain Adult Patients with Newly Diagnosed or Secondary Acute Myeloid Leukemia (AML)03.02.2020 Pfizer Provides Comment on COVID-19 White House Meeting01.23.2020 Pfizer Brings Three New Biosimilars to U.S. Patients at Substantial Discounts11.15.2019 Pfizer Announces CHMP Opinion for XELJANZ® (tofacitinib) in the European Union Related to Ongoing Review of the Product10.18.2019 Pfizer Statement on Vincristine Sulfate Injection, USP Supply in the United States10.17.2019 Pfizer Statement on Results of Pay Equity Study and Opportunity Parity Among Colleagues Worldwide09.17.2019 TrialSpark and Pfizer collaborating to improve speed and access to clinical trials09.17.2019 Terry Bradshaw and Pfizer Educate Boomers About the Risks of Pneumococcal Pneumonia and the Importance of Vaccination09.12.2019 Catalia Health and Pfizer collaborate to better understand patient journeys using artificial intelligence and via robot wellness coach09.06.2019 Hospira, Inc., Issues A Voluntary Nationwide Recall for one lot of BACTERIOSTATIC WATER for Injection, USP, due to a Potential Lack of Sterility Assurance.09.01.2019 Findings Released from NAXOS, a French Real-World Data Analysis and the Largest Real-World Data Analysis on Oral Anticoagulant Effectiveness and Safety in Europe Among Patients with Non-Valvular Atrial Fibrillation08.14.2019 Pfizer Inc. Issues A Voluntary Nationwide Recall For 2 Lots of RELPAX® (eletriptan hydrobromide) 40 mg Tablets Due to Potential Microbiological Contamination of Non-Sterile Products07.26.2019 Pfizer Statement on Update to XELJANZ® (tofacitinib) Prescribing Information in the United States05.17.2019 Pfizer confirms initiation of EU review of Tofacitinib with interim recommendations04.26.2019 Pfizer Inc. Issues A Voluntary Nationwide Consumer Level Recall of One Lot of ThermaCare® Back Pain Therapy HeatWraps, up to 16HR pain relief, Due To Out of Specification Results for High Cell Temperature03.18.2019 Hospira, Inc. Issues A Voluntary Nationwide Recall of 8.4% Sodium Bicarbonate Injection, USP Due To The Presence of Particulate Matter.Pagination Current page 1 Page 2 Page 3 Page 4 Page 5Next pageNext ›Last pageLast »Press Release ArchivePress StatementsPodcastsThe Antigen Podcast Season 1The Antigen Podcast Episode 1: Vaccines 101The Antigen Podcast Episode 2: The History of VaccinesThe Antigen Podcast Episode 3: Global Perspectives, Barriers & SolutionsThe Antigen Podcast Episode 4: Vaccine Hesitancy Part 1The Antigen Podcast Episode 5: Vaccine Hesitancy Part 2The Antigen Podcast Episode 6: Vaccine Politics, Policy & AdvocacyThe Antigen Podcast Episode 7: Innovations in the Vaccine LandscapeThe Antigen Podcast Episode 8: What's Next?The Antigen Podcast Season 2Get Science PodcastDiverse Perspectives Podcastmenopause: unmutedContact Media RelationsPress Kits & DownloadsCompany Press KitBreast Cancer: A Story Half Told Press KitPfizer Oncology Press KitPSA NarrativeInaccessibleRare Disease Gene Therapy Press KitTTR-Amyloidosis Press KitUC NarrativeOnline Pfizer Press KitCompany Press KitView the Pfizer Company Press KitPress StatementsView Pfizer's latest press statements Related ArticlesYour HealthFour Ways to Remain Vigilant About COVID-19 This Fourth of July…Your HealthUnderstanding Social Distancing: How Far is Enough?Our PurposePfizer Partners with Wellcome to Combat Antimicrobial Resistance…Our PurposeAge: Addressing a Blind Spot in Cancer CareOur PurposeAmid COVID-19 Global Pandemic, The Pfizer Foundation Helps IRC…Your HealthExposing Rheumatoid Arthritis (RA) Through Photography: CommunityAnnouncing the Pfizer Breakthrough Growth InitiativeYour HealthAsk an Expert: Professor Joe Schmitt Talks Tick-Borne…Our PeopleGiving Back To The Community: Pearl River, NY EditionOur PurposePfizer Partners with Direct Relief to Provide Critical COVID-19…Your HealthHealth Disparities Among Asian Americans and Pacific IslandersOur PeopleScientist at Home: Dan Xu – Many Roles, One PersonYour HealthFinding Answers for People with Chronic Inflammatory and…Your HealthHow to Avoid Pharmaceutical Scams During COVID-19Our ScienceWhat Makes an RNA Vaccine Different From a Conventional Vaccine?Our ScienceGet the Facts on Our COVID-19 Vaccine CandidatesOur ProductsScaling Up to Manufacture and Supply a COVID-19 Vaccine, If…Your HealthEmotional Well-Being Tips for People Living with Chronic…Our ScienceHow Are Vaccines Developed?Our PeopleA Day in the Life of a Scientist (In the time of Coronavirus)Your HealthUnderstanding the Impact of COVID-19 and Tips for Those Living…ShowHide
